SHISX Holdings Information

SHISX is a mutual fund with a total of 159 individual holdings. The top holdings are Eli Lilly and Company stock at 12.68%, Johnson & Johnson at 7.87%, UnitedHealth Group at 6.34%, Merck & Co. at 5.26%, and AbbVie at 5.11%.

Total Holdings

159

Top 10 Percentage

53.00%

Asset Class

Equity

Fund Category

Health

Assets

6.09B

Forward PE Ratio

20.62

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	12.68%	656,650
2	JNJ	Johnson & Johnson	7.87%	1,924,600
3	UNH	UnitedHealth Group Incorporated	6.34%	947,412
4	MRK	Merck & Co., Inc.	5.26%	2,543,755
5	ABBV	AbbVie Inc.	5.11%	1,261,298
6	GILD	Gilead Sciences, Inc.	3.74%	1,841,333
7	AMGN	Amgen Inc.	3.44%	590,203
8	TMO	Thermo Fisher Scientific Inc.	3.18%	393,848
9	VRTX	Vertex Pharmaceuticals Incorporated	2.89%	361,907
10	EW	Edwards Lifesciences Corporation	2.49%	1,710,975
11	ABT	Abbott Laboratories	1.99%	1,361,894
12	DHR	Danaher Corporation	1.98%	645,138
13	ELV	Elevance Health, Inc.	1.88%	302,439
14	PFE	Pfizer Inc.	1.49%	3,851,976
15	ARGX	argenx SE	1.33%	88,995
16	BIIB	Biogen Inc.	1.27%	364,188
17	TEVA	Teva Pharmaceutical Industries Limited	1.17%	2,140,996
18	ISRG	Intuitive Surgical, Inc.	1.15%	180,369
19	SYK	Stryker Corporation	1.12%	221,948
20	RVMD	Revolution Medicines, Inc.	1.09%	361,340
21	MRNA	Moderna, Inc.	1.00%	891,317
22	BSX	Boston Scientific Corporation	1.00%	1,452,020
23	WAT	Waters Corporation	1.00%	165,075
24	TSTXX	BlackRock Liquidity T-Fund Instl	0.95%	59,029,950
25	CYTK	Cytokinetics, Incorporated	0.89%	649,484

Showing 25 of 159 holdings

Subscribe to see the full list

Activate Now

As of Jun 30, 2026